Ben Ward - Author for 24/7 Wall St.
Lastest Stories by Ben Ward
Nautilus Pops 7.8% After Hours as Board Launches Strategic Review Including Potential Sale of Compan
Shares of fitness equipment brand owner Nautilus rallied after an announcement by the board that stated that it had launched a comprehensive strategic review of the company.
Published:
SilverBow Resources has received a 13D filing from activist investor Kimmeridge Energy Management disclosing an almost 15% stake in the company.
Published:
Clinical-stage biopharma company Minerva Neurosciences may soon see another significant rally as a result of a short squeeze.
Published:
Activist investor Mason P. Slaine has disclosed a 5% stake in American newspaper media company Lee Enterprises.
Published:
News that activist investment firm Jana Partners had plans to push Freshpet to make changes has boosted shares.
Published:
iRhythm Technologies investors had a tough end to the week with the stock sliding 21%.
Published:
J.P. Morgan has a positive view on the revenue opportunities in multiple end-markets for the LiDAR (light detection and ranging) industry.
Published:
Shopping Center REIT Macerich reported that its CEO purchased 22,200 shares on the open market.
Published:
Global cannabis industry leader Aurora has released fourth-quarter and full-year results.
Published:
Humacyte said that Ayabudge, whose principals include the company's CEO and her husband, its former board chairman and a director, sold nearly 19 million share for just over $6 million.
Published:
Here is a look at five Canadian stocks whose dividends may offer what today's investor seeks.
Published:
Fuel cell system manufacturer Advent Technologies ended the week more than 20% higher after news of a new Memorandum of Understanding that was signed with a Saudi-based company.
Published:
Adobe was the talking point of U.S. equity markets on Thursday after announcing a huge $20 billion dollar acquisition of web-based collaboration design platform Figma.
Published:
This year's market rout has savvy investors playing defense and buying dividend-paying, steady performers over momentum growth stocks.
Published:
Inotiv's chief operating officer on Tuesday reportedly bought 8,900 shares of company stock at $22.34 per share, or $198,000.
Published: